Management of cerebral vasospasm

Neurosurgical Review

Volumn 29, Issue 3, 2006, Pages 179-193

  Loch Macdonald, R ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cerebral aneurysm; Cerebral infarction; Cerebral ischemia; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ANTICONVULSIVE AGENT; ANTIOXIDANT; CLAZOSENTAN; DIHYDROPYRIDINE; ENDOTHELIN; FASUDIL; GLUCOCORTICOID; ICOSANOID; INFUSION FLUID; MAGNESIUM; MAGNESIUM SULFATE; MANNITOL; NICARDIPINE; NIMODIPINE; NITRIC OXIDE; PARACETAMOL; PLACEBO; PROSTACYCLIN; SODIUM CHLORIDE; STEROID; TAK 044; TIRILAZAD; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VASOCONSTRICTOR AGENT;

ANGIOPLASTY; BLOOD TRANSFUSION; BODY TEMPERATURE DISORDER; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PROTECTION; BRAIN VASOSPASM; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; HYPERTHERMIA; HYPERVOLEMIA; HYPONATREMIA; HYPOTENSION; HYPOVOLEMIA; INTENSIVE CARE; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROPATHOLOGY; NEUROSURGERY; NONHUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PEROPERATIVE CARE; PHYSICAL MEDICINE; POSTOPERATIVE CARE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; BRAIN ANGIOGRAPHY; BRAIN CIRCULATION; PATHOLOGY; PHYSIOLOGY;

ANGIOPLASTY; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; HUMANS; SUBARACHNOID HEMORRHAGE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL;

EID: 33746894149     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-005-0013-5     Document Type: Review

References (127)

1. Aaslid R, Huber P, Nornes H (1984) Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 60:37-41
2. Aiyagari V, Cross DT, III, Deibert E, Dacey RG Jr, Diringer MN (2001) Safety of hemodynamic augmentation in patients treated with Guglielmi detachable coils after acute aneurysmal subarachnoid hemorrhage. Stroke 32:1994-1997
3. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou, SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey, FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR (1983) Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619-624
4. Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE (1999) Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery 44:1113-1116
5. Anderson GB, Ashforth R, Steinke DE, Findlay JM (2000) CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage. Am J Neuroradiol 21:1011-1015
6. Asplund K, Israelsson K, Schampi I (1999) Haemodilution for acute ischaemic stroke (Cochrane review). Cochrane Library 2, pp 1-22. Update Software, Oxford
7. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA (2004) Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 25:819-826
8. Baldwin ME, Macdonald RL, Huo D, Novakovia RL, Goldenberg FD, Frank JI, Rosengart AJ (2004) Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 35:2506-2511
9. Barker FG, Ogilvy CS (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405-414
10. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins AL, III, Vallabhajosyula P (1998) Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 42:352-360
11. Bejjani GK, Bank WO, Olan WJ, Sekhar LN (1998) The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Subsequent experience shows that balloon angioplasty may be indicated in patients with clipped or coiled aneurysms who deteriorate from vasospasm despite hemodynamic therapy. Neurosurgery 42:979-986
12. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, Van ER (2004) Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 25:1067-1076
13. Boet R, Mee E (2000) Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. Neurosurgery 47:602-607
14. Brewer RP, Parra A, Lynch J, Chilukuri V, Borel CO (2001) Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol 13:202-206
15. Brock H, Gabriel C, Bibl D, Necek S (2002) Monitoring intravascular volumes for postoperative volume therapy. Eur J Anaesthesiol 19:288-294
16. Chia RY, Hughes RS, Morgan MK (2002) Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 9:279-281
17. Claassen J, Hirsch LJ, Kreiter KT, Du EY, Sander CE, Emerson RG, Mayer SA (2004) Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol 115:2699-2710
18. Clyde BL, Resnick DK, Yonas H, Smith HA, Kaufmann AM (1996) The relationship of blood velocity as measured by transcranial Doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage. Neurosurgery 38:896-904
19. Coyne TJ, Montanera WJ, Macdonald RL, Wallace MC (1994) Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 37:391-396
20. Dorsch NWC (1994) A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part 2: Management. J Clin Neurosci 1:78-92
21. Dorsch NWC, King MT (1994) A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part 1: Incidence and effects. J Clin Neurosci 1:19-26
22. Dorsch NW, Kassell NF, Sinkula MS (2001) Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH. Acta Neurochir Suppl 77:233-235
23. Drake CG, Hunt WE, Sano K, Kassell N, Teasdale G, Pertuiset B, DeVilliers JC (1988) Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985-986
24. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS (2003) Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:123-133
25. Ecker A, Riemenschneider PA (1951) Arteriographic demonstration of spasm of the intracranial arteries with special reference to saccular arterial aneurysms. J Neurosurg 8:660-667
26. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B (2001) Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 49:593-605
27. Eskridge JM, Newell DW, Pendleton GA (1990) Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am 1:387-399
28. Espinosa F, Weir B, Shnitka T, Overton T, Boisvert D (1984) A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings. J Neurosurg 60:1176-1185
29. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J (2000) Calcium antagonists for aneurysmal subarachnoid haemorrhage (review). Cochrane Database Syst Rev CD000277
30. Findlay JM (2005) Intracisternal thrombolysis with tissue plasminogen activator for severe aneurysmal subarachnoid hemorrhage. In: Macdonald RL (ed) Cerebral vasospasm. Advances in research and treatment. Thieme, New York, pp 304-307
31. Findlay JM, Weir BK, Gordon P, Grace M, Baughman R (1989) Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 24:491-498
32. Findlay JM, Weir BK, Kanamaru K, Grace M, Baughman R (1990) The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 26:201-206
33. Findlay JM, Weir BK, Kanamaru K, Grace M, Baughman R (1990) The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurgery 75:181-188
34. Findlay JM, Kassell NF, Weir BK, Haley ECJ, Kongable G, Germanson, Truskowski L, Alves WM, Holness RO, Knuckey NW (1995) A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-176
35. Fisher CM, Roberson GH, Ojemann RG (1977) Cerebral vasospasm with ruptured saccular aneurysm - the clinical manifestations. Neurosurgery 1:245-248
36. Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9
37. Goldsher D, Shreiber R, Shik V, Tavor Y, Soustiel JF (2004) Role of multisection CT angiography in the evaluation of vertebrobasilar vasospasm in patients with subarachnoid hemorrhage. AJNR Am J Neuroradiol 25:1493-1498
38. Haley EC Jr, Kassell NF, Torner JC (1993) A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 78:548-553
39. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA (1995) Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790
40. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM (1997) A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467-474
41. Hamada JI, Kai Y, Morioka M, Yano S, Mizuno T, Hirano T, Kazekawa K, Ushio Y (2003) Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna. A prospective randomized study. Stroke 34:2549-2554
42. Hasan D, Wijdicks EF, Vermeulen M (1990) Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 27:106-108
43. Heran NS, Hentschel SJ, Toyota BD (2004) Jugular bulb oximetry for prediction of vasospasm following subarachnoid hemorrhage. Can J Neurol Sci 31:80-86
44. Hoh BL, Carter BS, Ogilvy CS (2002) Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy. Neurosurgery 50:1207-1211
45. Hoh BL, Topcuoglu MA, Singhal AB, Pryor JC, Rabinov JD, Rordorf GA, Carter BS, Ogilvy CS (2004) Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 55:779-789
46. Hop JW, Rinkel GJ, Algra A, Berkelbach van der Sprenkel JW, van Gijn J (2000) Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 54:872-878
47. Hunt WE, Hess RM (1968) Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14-20
48. Jahromi BS, Aihara Y, Yassari R, Nikitina E, Ryan D, Weyer G, Agbaje-Williams M, Macdonald RL (2005) Potassium channels in experimental cerebral vasospasm. In: Cerebral vasospasm. Advances in research and treatment. In: Macdonald RL (ed) Cerebral vasospasm. Advances in research and treatment. Thieme, New York, pp 20-24
49. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K (1992) Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage (comment). J Neurosurg 77:842-847
50. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP (1982) Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337-343
51. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL (1990) The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18-36
52. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS (1992) Treatment of cerebral vasospasm with intra-arterial papaverine (comment). J Neurosurg 77:848-852
53. Kassell NF, Haley ECJ, Apperson-Hansen C, Alves WM (1996) Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand (comment). J Neurosurg 84:221-228
54. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T (2002) Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 33:1011-1015
55. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T, Fisher CM (1983) The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 33:424-436
56. Klingelhofer J, Dander D, Holzgraefe M, Bischoff C, Conrad B (1991) Cerebral vasospasm evaluated by transcranial Doppler ultrasonography at different intracranial pressures. J Neurosurg 75:752-758
57. Kosnik EJ, Hunt WE (1976) Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 45:148-154
58. Lanzino G, Kassell NF (1999) Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90:1018-1024
59. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM (1999) Double blind, randomized, vehicle controlled study of high dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90:1011-1017
60. Lee SH, Heros RC (1994) Principles of management of subarachnoid hemorrhage: steroids. In: Ratcheson RA, Wirth FP (eds) Ruptured cerebral aneurysms: perioperative management. Williams and Wilkins, Baltimore, pp 77-85
61. Leffers AM, Wagner A (2000) Neurologic complications of cerebral angiography. A retrospective study of complication rate and patient risk factors. Acta Radiol 41:204-210
62. Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA (2000) Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31:383-391
63. LeRoux PD, Elliott JP, Grady MS, Newell DW, Mayberg MR, Winn HR (1994) Anterior circulation aneurysms: improvement in outcome in good-grade patients 1983-1993. Clin Neurosurg 41:325-333
64. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P (1988) Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl 42:81-84
65. Liszczak TM, Varsos VG, Black PM, Kistler JP, Zervas NT (1983) Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 58:18-26
66. Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT (2005) Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36:2024-2026
67. Macdonald RL (1995) Cerebral vasospasm. Neurosurg Q 5:73-97
68. Macdonald RL, Weir B (2001) Cerebral vasospasm. Academic, San Diego
69. Macdonald RL, Rosengart A, Huo D, Karrison T (2003) Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 99:644-652
70. Mayberg MR, Okada T, Bark DH (1990) The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 72:634-640
71. Mee E, Dorrance D, Lowe D, Neil-Dwyer G (1988) Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 22:484-491
72. Mizukami M, Kawase T, Usami T, Tazawa T (1982) Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 10:301-307
73. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267-1274
74. Muir KW, Lees KR, Ford I, Davis S (2004) Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 363:439-445
75. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Sander CE, Mayer SA, Fitzsimmons BF (2005) Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36:583-587
76. Nosko M, Weir BK, Lunt A, Grace M, Allen P, Mielke B (1987) Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg 66:416-422
77. Ohkuma H, Manabe H, Tanaka M, Suzuki S (2000) Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31:1621-1627
78. Ohman J, Heiskanen O (1988) Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69:683-686
79. Ohta H, Yasui N, Suzuki A, Ito Z (1982) Hemorrhagic infarction following vasospasm due to ruptured intracranial aneurysms in Japanese). Neurol Med Chir 22:716-724
80. Oppelt WW, MacIntyre I, Rall DP (1963) Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 205:959-962
81. Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons BF, Janjua N, Mayer SA, Connolly ES Jr (2005) Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56:476-484
82. Pasqualin A, Rosta L, Da Pian R, Cavazzani P, Scienza R (1984) Role of computed tomography in the management of vasospasm after subarachnoid hemorrhage. Neurosurgery 15:344-353
83. Peerless SJ (1979) Pre- and postoperative management of cerebral aneurysms. Clin Neurosurg 26:209-231
84. Peterson JW, Kwun BD, Hackett JD, Zervas NT (1990) The role of inflammation in experimental cerebral vasospasm. J Neurosurg 72:767-774
85. Petruk KC, West M, Mohr G, Weir BK, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505-517
86. Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 82:110-114
87. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636-642
88. Rabinstein AA, Pichelmann MA, Friedman JA, Piepgras DG, Nichols DA, McIver JI, Toussaint LG, III, McClelland RL, Fulgham JR, Meyer FB, Atkinson JL, Wijdicks EF (2003) Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 98:319-325
89. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL (2004) Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 101:255-261
90. Rinkel GJ, Feigin VL, Algra A, van Gijn J (2004) Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev CD000483
91. Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, Laloe V, Munoz-Sanchez A, Arango M, Hartzenberg B, Khamis H, Yutthakasemsunt S, Komolafe E, Olldashi F, Yadav Y, Murillo-Cabezas F, Shakur H, Edwards P (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364:1321-1328
92. Roos Y, Rinkel G, Vermeulen M, Algra A, van Gijn J (2003) Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a Cochrane review. Stroke 34:2308-2309
93. Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH (1983) Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery 12:658-661
94. Sasaki T, Kodama N, Kawakami M, Sato M, Asari J, Sakurai Y, Watanabe K, Onuma T, Matsuda T (2000) Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. A study of urokinase concentration and the fibrinolytic system. Stroke 31:1256-1262
95. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G (2000) Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275:21722-21729
96. Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP (2004) Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med 32:1272-1276
97. Seifert V, Stolke D, Zimmermann M, Feldges A (1994) Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Acta Neurochir 128:137-143
98. Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM (2000) Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 93:992-997
99. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata, Kikuchi H, Takemae T, Hidaka H (1992) Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571-577
100. Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ (2005) SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64:1008-1013
101. Skjoth-Rasmussen J, Schulz M, Kristensen SR, Bjerre P (2004) Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 100:8-15
102. Sloan MA, Haley ECJ, Kassell NF, Henry ML, Stewart SR, Beskin RR, Sevilla EA, Torner JC (1989) Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology 39:1514-1518
103. Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP, Setty D, Lawton MT, Young WL, Higashida RT, Halbach VV (2004) Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 35:2518-2522
104. Stiefel MF, Heuer GG, Abrahams JM, Bloom S, Smith MJ, Maloney-Wilensky E, Grady MS, LeRoux PD (2004) The effect of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage. J Neurosurg 101:594-599
105. Suzuki J, Komatsu S, Sato T, Sakurai Y (1980) Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid haemorrhage. Acta Neurochir 55:63-70
106. Suzuki S, Suzuki M, Iwabuchi T, Kamata Y (1983) Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report. Neurosurgery 13:199-203
107. Takagi R, Hayashi H, Kobayashi H, Kumazaki T, Isayama K, Ikeda Y, Teramoto A (1998) Three-dimensional CT angiography of intracranial vasospasm following subarachnoid haemorrhage. Neuroradiology 40:631-635
108. Tamatani S, Sasaki O, Takeuchi S, Fujii Y, Koike T, Tanaka R (1997) Detection of delayed cerebral vasospasm, after rupture of intracranial aneurysms, by magnetic resonance angiography (comment). Neurosurgery 40:748-753
109. Touho H, Karasawa J, Ohnishi H, Shishido H, Yamada K, Shibamoto K (1992) Evaluation of therapeutically induced hypertension in patients with delayed cerebral vasospasm by xenon-enhanced computed tomography. Neurol Med Chir 32:671-678
110. Toyota BD (1999) The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage. J Neurosurg 90:203-206
111. Treggiari MM, Walder B, Suter PM, Romand JA (2003) Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984
112. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36:1627-1632
113. Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P (2003) Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 98:1227-1234
114. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103:9-17
115. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ (2003) Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir (Wien ) 145:195-199
116. Vermeij FH, Hasan D, Bijvoet HW, Avezaat CJ (1998) Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage. Stroke 29:924-930
117. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM (2002) Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:510-514
118. Voldby B, Enevoldsen EM, Jensen FT (1985) Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 62:59-67
119. Vorkapic P, Bevan JA, Bevan RD (1991) Longitudinal in vivo and in vitro time-course study of chronic cerebrovasospasm in the rabbit basilar artery. Neurosurg Rev 14:215-219
120. Weir B, Grace M, Hansen J, Rothberg C (1978) Time course of vasospasm in man. J Neurosurg 48:173-178
121. Wijdicks EF, Ropper AH, Hunnicutt EJ, Richardson GS, Nathanson JA (1991) Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 22:1519-1524
122. Yamakami I, Isobe K, Yamaura A, Nakamura T, Makino H (1983) Vasospasm and regional cerebral blood flow (rCBF) in patients with ruptured intracranial aneurysm: serial rCBF studies with the xenon-133 inhalation method. Neurosurgery 13:394-401
123. Yano K, Kuroda T, Tanabe Y, Yamada H (1993) Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy. Acta Neurochir 125:15-19
124. Yundt KD, Grubb RL Jr, Diringer MN, Powers WJ (1998) Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab 18:419-424
125. Zhang ZD, Yamini B, Komuro T, Ono S, Johns L, Marton LS, Weir B, Macdonald RL (2001) Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Stroke 32:1868-1874
126. Zimmermann M, Seifert V (1998) Endothelin and subarachnoid hemorrhage: an overview (review). Neurosurgery 43:863-875
127. Zubkov YN, Nikiforov BM, Shustin VA (1984) Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir 70:65-79